Sercan Karabulut | Psychiatry | Best Academic Researcher Award

Assoc. Prof. Dr. Sercan Karabulut | Psychiatry | Best Academic Researcher Award

Akdeniz University School of Medicine | Turkey

Dr. Sercan Karabulut is a distinguished psychiatrist and academic with a strong educational background from İstanbul Medicine Faculty and earlier training at leading Turkish schools. He completed his residency in psychiatry at İstanbul Medicine Faculty and is fluent in English and German, which has supported his international academic presence. His professional career includes service at prominent state hospitals in Antalya and Van, with his current appointment at Akdeniz University School of Medicine. His research interests span schizophrenia, bipolar disorder, substance use disorders, neuroinflammation, neurodegeneration, personality traits, psychopharmacology, and the cognitive and clinical aspects of addiction. He has published extensively in national and international journals, addressing key issues such as clozapine use in schizophrenia, cognitive impairments in methamphetamine users, psychiatric outcomes of encephalitis, and the interplay between trauma, empathy, and substance use. His research skills include clinical psychiatry, psychometric evaluation, statistical analysis, study design, and long-term patient follow-up. In addition, he has authored book chapters on addiction and psychiatric care and has actively contributed to scientific congresses through oral presentations, panels, and case reports. Recognized for his academic productivity and dedication, he has received honors in scientific meetings and has gained respect as both a clinician and researcher. Overall, Dr. Karabulut’s career demonstrates a sustained commitment to advancing psychiatry through clinical practice, research, and education, making him a valuable contributor to the understanding and treatment of complex psychiatric and addiction-related disorders.

Profile: ORCID

Featured Publications

Korchia Theo | Psychiatry | Best Researcher Award

Dr. Korchia Theo | Psychiatry | Best Researcher Award

Dr. Théo Korchia 🇫🇷 is a French psychiatrist specializing in early-onset schizophrenia 🧩, with a passion for innovation in mental health care 💡. Based at Aix-Marseille University and APHM 🏥, he completed a research fellowship at McGill University in Montreal 🇨🇦. His groundbreaking work emphasizes personalizing antipsychotic treatment using pharmacogenetics 🧬, improving patient adherence and quality of life ❤️. His notable contributions include addressing sexual dysfunction in schizophrenia treatment 💔, a topic often neglected. He published a major meta-analysis in JAMA Psychiatry 📘, shedding light on its prevalence. Winner of the Schizophrenia International Research Society award 🏆, Dr. Korchia advocates for a psychiatry that is humane, patient-centered, and scientifically rigorous 🔬. His work not only enhances clinical outcomes but also builds stronger therapeutic alliances through trust and transparency 🤝. Driven by compassion and innovation, he envisions a future where mental health care is personalized, inclusive, and profoundly impactful 🌍.

Profile

Education 🎓

Théo Korchia began his medical education in France 🎓, obtaining his degree in psychiatry with a focus on early-onset psychotic disorders 🧠. Supported by Aix-Marseille University and APHM 🏥, his academic journey was enriched by international exposure at McGill University 🇨🇦, where he deepened his expertise in psychiatric research and pharmacogenetics 🧬. His commitment to academic excellence led to extensive training in clinical practice, psychopharmacology, and patient-centered care 🩺. Throughout his studies, he explored the intersection of pharmacology, genetics, and psychiatry, aiming to personalize schizophrenia treatment for better efficacy and fewer side effects 🧪. His education was marked by a strong emphasis on translational research, ethics, and therapeutic alliance 🤝. Dr. Korchia continues to be involved in academic teaching and mentoring, sharing his knowledge with students and young professionals 📚. His education forms the bedrock of his mission: to evolve psychiatric care into a more compassionate, evidence-based, and individualized discipline 🌟.

Experience 👨‍🏫

Dr. Korchia’s clinical journey began in France 🇫🇷 at APHM and Aix-Marseille University 🏥, where he treated patients with early-onset schizophrenia and related psychotic disorders 🧠. His international experience includes a transformative year of research at McGill University 🇨🇦, focusing on pharmacogenetics and treatment personalization 🧬. In both hospital and research settings, he has contributed to improving psychiatric care through innovative approaches, especially regarding the management of antipsychotic side effects 🩻. With a hands-on approach, he integrates patient voices in treatment plans 🗣️, fostering therapeutic alliance and adherence 🤝. He has collaborated with multidisciplinary teams, presented findings at international conferences 🌐, and published in high-impact journals like JAMA Psychiatry 📘. Passionate about breaking stigmas, Dr. Korchia also advocates for the recognition of sexual dysfunction in psychiatric care 💔. His experience bridges cutting-edge science and compassionate care, making him a leading voice in progressive psychiatry 💡.

Awards & Recognitions 🏅

Dr. Théo Korchia was honored by the Schizophrenia International Research Society 🏆 for his pioneering research in early-onset schizophrenia treatment 🧠. He was supported by Aix-Marseille University and the Assistance Publique des Hôpitaux de Marseille 🎓🏥, which facilitated his international research fellowship at McGill University 🇨🇦. His impactful publication in JAMA Psychiatry 📘—a meta-analysis involving 21,000+ patients—highlighted sexual dysfunction prevalence in schizophrenia, earning him global recognition 🌍. His work addressing often-ignored dimensions of psychiatric care, such as sexual health 💔, has been lauded for its clinical relevance and humanistic perspective. Known for combining scientific rigor 🔬 with empathy ❤️, he is frequently invited to share insights at conferences and symposiums worldwide 🎤. These accolades reflect not only academic excellence but also his commitment to enhancing patient-centered care 🧩. Dr. Korchia’s recognition symbolizes a growing awareness of the holistic needs of individuals with mental illness 🌟.

Research Interests 🔬

Dr. Korchia’s research centers on early-onset schizophrenia 🧠, with a sharp focus on pharmacogenetics 🧬 to personalize antipsychotic treatments and minimize side effects. He addresses the often-overlooked issue of sexual dysfunction 💔 in schizophrenia, a side effect that significantly impacts quality of life and treatment adherence 📉. His landmark meta-analysis in JAMA Psychiatry 📘 quantified this burden, influencing clinical guidelines and public discourse. He explores how integrating patient perspectives and improving therapeutic alliances 🤝 can enhance outcomes. His work bridges biological psychiatry and patient-centered care 🩺, emphasizing that innovation is not just drug development, but rethinking care models to reflect human experience 🧠❤️. He champions the inclusion of sexual health in risk-benefit analysis of psychiatric medications 💡. Ultimately, Dr. Korchia’s goal is to evolve psychiatry into a more humane, personalized, and effective field—where each treatment plan respects the unique biology and lived experience of the individual 🌍.

Publications 
  • Impact of perceived side-effects of psychotropic treatments on quality of life in patients with severe mental illness

    Dialogues in Clinical Neuroscience
    2025-12-31 | Journal article
    CONTRIBUTORS: Théo Korchia; Mélanie Faugère; Vincent Achour; Eloïse Maakaron; Christelle Andrieu-Haller; Guillaume Fond; Christophe Lançon
  • Lifetime sexual violence experienced by women asylum seekers and refugees hosted in high-income countries: Literature review and meta-analysis

    Journal of Forensic and Legal Medicine
    2024-01 | Journal article
    CONTRIBUTORS: Laura Cayreyre; Théo Korchia; Anderson Loundou; Maeva Jego; Didier Théry; Julie Berbis; Gaëtan Gentile; Pascal Auquier; Jérémy Khouani
  • Sexual Dysfunction in Schizophrenia

    JAMA Psychiatry
    2023-11-01 | Journal article
    Part ofISSN: 2168-622X
    CONTRIBUTORS: Théo Korchia; Vincent Achour; Mélanie Faugere; Ali Albeash; Dong Keon Yon; Laurent Boyer; Guillaume Fond
  • Utilizing pharmacogenetics when treating first episode psychosis

    Journal of Psychiatry and Neuroscience
    2023-01-03 | Journal article
    Part of ISSN: 1180-4882
    CONTRIBUTORS: Theo Korchia; Ridha Joober; Raphaelle Richieri; Priyadharshini Sabesan; Lena Palaniyappan